PDE11A
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A
Also known as: PDE11_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCR9
- Gene
- PDE11A
- Ensembl
- ENSG00000128655
- Chromosome
- 2
- Canonical length
- 933 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Centriolar satellite,Basal body
OverviewNCBI Gene
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
933 residues, UniProt reviewed canonical sequence.
>Q9HCR9|PDE11A
1 MAASRLDFGE VETFLDRHPE LFEDYLMRKG KQEMVEKWLQ RHSQGQGALG PRPSLAGTSS
61 LAHSTCRGGS SVGGGTGPNG SAHSQPLPGG GDCGGVPLSP SWAGGSRGDG NLQRRASQKE
121 LRKSFARSKA IHVNRTYDEQ VTSRAQEPLS SVRRRALLRK ASSLPPTTAH ILSALLESRV
181 NLPRYPPTAI DYKCHLKKHN ERQFFLELVK DISNDLDLTS LSYKILIFVC LMVDADRCSL
241 FLVEGAAAGK KTLVSKFFDV HAGTPLLPCS STENSNEVQV PWGKGIIGYV GEHGETVNIP
301 DAYQDRRFND EIDKLTGYKT KSLLCMPIRS SDGEIIGVAQ AINKIPEGAP FTEDDEKVMQ
361 MYLPFCGIAI SNAQLFAASR KEYERSRALL EVVNDLFEEQ TDLEKIVKKI MHRAQTLLKC
421 ERCSVLLLED IESPVVKFTK SFELMSPKCS ADAENSFKES MEKSSYSDWL INNSIAELVA
481 STGLPVNISD AYQDPRFDAE ADQISGFHIR SVLCVPIWNS NHQIIGVAQV LNRLDGKPFD
541 DADQRLFEAF VIFCGLGINN TIMYDQVKKS WAKQSVALDV LSYHATCSKA EVDKFKAANI
601 PLVSELAIDD IHFDDFSLDV DAMITAALRM FMELGMVQKF KIDYETLCRW LLTVRKNYRM
661 VLYHNWRHAF NVCQLMFAML TTAGFQDILT EVEILAVIVG CLCHDLDHRG TNNAFQAKSG
721 SALAQLYGTS ATLEHHHFNH AVMILQSEGH NIFANLSSKE YSDLMQLLKQ SILATDLTLY
781 FERRTEFFEL VSKGEYDWNI KNHRDIFRSM LMTACDLGAV TKPWEISRQV AELVTSEFFE
841 QGDRERLELK LTPSAIFDRN RKDELPRLQL EWIDSICMPL YQALVKVNVK LKPMLDSVAT
901 NRSKWEELHQ KRLLASTASS SPASVMVAKE DRNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE11A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 9.7 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 9.7 nTPM
- liver: 5.9 nTPM
- prostate: 5.1 nTPM
- skeletal muscle: 4.3 nTPM
- testis: 3.4 nTPM
- spinal cord: 2.7 nTPM
Single-cell type
- prostatic glandular cells: 1,932 nCPM
- respiratory ionocytes: 356 nCPM
- breast lactating cells: 271 nCPM
- adipocytes: 146 nCPM
- myonuclei: 103 nCPM
- salivary ionocytes: 98 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
Brain region
- spinal cord: 8.8 nTPM
- white matter: 7.4 nTPM
- pons: 6.3 nTPM
- medulla oblongata: 6 nTPM
- midbrain: 5.3 nTPM
- hypothalamus: 5.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDE11A.
Disease | AllUniProt
Conditions PDE11A is implicated in, by any mechanism.
- Primary pigmented nodular adrenocortical disease 2 (PPNAD2) MIM:610475
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 273 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pigmented nodular adrenocortical disease, primary, 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cAMP/PKA signal transduction
- negative regulation of cGMP-mediated signaling
- signal transduction
Molecular functions
- 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- cGMP binding
- metal ion binding
- cyclic-nucleotide phosphodiesterase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- GAF domain
- HD/PDEase domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- GAF-like domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase
- GAF domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE11A as an antibody target. Whether an autoantibody or antibody against PDE11A could matter depends on whether native PDE11A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE11A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE11A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...